MCID: PRM151
MIFTS: 27

Primary Bone Lymphoma

Categories: Blood diseases, Rare diseases, Bone diseases, Immune diseases

Aliases & Classifications for Primary Bone Lymphoma

MalaCards integrated aliases for Primary Bone Lymphoma:

Name: Primary Bone Lymphoma 56
Primary Lymphoma of Bone 69

Characteristics:

Orphanet epidemiological data:

56
primary bone lymphoma
Age of onset: All ages; Age of death: any age;

Classifications:



External Ids:

Orphanet 56 ORPHA314684
ICD10 via Orphanet 34 C85,7 C85.7

Summaries for Primary Bone Lymphoma

MalaCards based summary : Primary Bone Lymphoma, also known as primary lymphoma of bone, is related to lymphoma and bone lymphoma. The drugs Doxorubicin and Doxil have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and t cells.

Related Diseases for Primary Bone Lymphoma

Diseases related to Primary Bone Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 12)
id Related Disease Score Top Affiliating Genes
1 lymphoma 10.5
2 bone lymphoma 10.5
3 b-cell lymphomas 9.7
4 diffuse large b-cell lymphoma 9.7
5 osteomyelitis 9.7
6 thyroiditis 9.5
7 rheumatoid arthritis 9.5
8 arthritis 9.5
9 sarcoma 9.5
10 cauda equina syndrome 9.5
11 arthropathy 9.5
12 acquired immunodeficiency syndrome 9.5

Graphical network of the top 20 diseases related to Primary Bone Lymphoma:



Diseases related to Primary Bone Lymphoma

Symptoms & Phenotypes for Primary Bone Lymphoma

Drugs & Therapeutics for Primary Bone Lymphoma

Drugs for Primary Bone Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 463)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1 31703
3 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
4 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
5 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
6
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
7
Tacrolimus Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 104987-11-3 445643 439492
8
Mitoxantrone Approved, Investigational Phase 3,Phase 1,Phase 2 65271-80-9 4212
9
Daunorubicin Approved Phase 3,Phase 2,Phase 1 20830-81-3 30323
10
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
11
Etoposide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
12
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
13
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
14
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
15
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
16
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
17
Mycophenolic acid Approved Phase 3,Phase 2,Phase 1 24280-93-1 446541
18
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 2,Phase 1 128794-94-5 5281078
19
Fludarabine Approved Phase 3,Phase 2,Phase 1 21679-14-1, 75607-67-9 30751
20
Vidarabine Approved Phase 3,Phase 2,Phase 1 24356-66-9 32326 21704
21
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 55-98-1 2478
22
rituximab Approved Phase 3,Phase 2,Phase 1,Early Phase 1 174722-31-7 10201696
23
Bleomycin Approved Phase 3,Phase 1,Phase 2 11056-06-7 5360373
24
Ifosfamide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 3778-73-2 3690
25
Bortezomib Approved, Investigational Phase 2, Phase 3, Phase 1 179324-69-7 387447 93860
26
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
27
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
28
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
29
alemtuzumab Approved, Investigational Phase 2, Phase 3,Phase 1 216503-57-0
30 Thiotepa Approved Phase 3,Phase 2,Phase 1 52-24-4 5453
31
Lenograstim Approved Phase 3,Phase 2,Phase 1,Early Phase 1 135968-09-1
32
Clofarabine Approved, Investigational Phase 2, Phase 3, Phase 1 123318-82-1 119182
33
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
34
Carmustine Approved Phase 3,Phase 2,Phase 1 154-93-8 2578
35
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
36
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
37
Asparaginase Approved Phase 3,Phase 2,Phase 1 9015-68-3
38
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
39
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
40
Vinorelbine Approved, Investigational Phase 3,Phase 2 71486-22-1 60780 44424639
41
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
42
Gemcitabine Approved Phase 3,Phase 2,Phase 1 95058-81-4 60750
43
Morphine Approved, Investigational Phase 3,Phase 1 57-27-2 5288826
44
Dasatinib Approved, Investigational Phase 2, Phase 3, Phase 1 302962-49-8 3062316
45
Pentostatin Approved, Investigational Phase 3,Phase 2,Phase 1 53910-25-1 40926 439693
46
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
47
Hydrocortisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
48
Adenosine Approved, Investigational Phase 3,Phase 2,Phase 1 58-61-7 60961
49
Ephedrine Approved Phase 3 299-42-3 9294
50
Zoledronic acid Approved Phase 3,Phase 1 118072-93-8 68740

Interventional clinical trials:

(show top 50) (show all 729)

id Name Status NCT ID Phase Drugs
1 Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma Completed NCT00969462 Phase 4 Doxorubicin
2 The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Recruiting NCT02905916 Phase 4 PEG-rhG-CSF
3 Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy Withdrawn NCT01841814 Phase 4
4 Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma Unknown status NCT00463463 Phase 3 90Yttrium Ibritumomab Tiuxetan (Zevalin)
5 Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image Unknown status NCT00172562 Phase 3
6 Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: Unknown status NCT02070523 Phase 3 VDCLD regimen
7 Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia Unknown status NCT00707083 Phase 3 dexamethasone;mercaptopurine;methotrexate;vincristine sulfate
8 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
9 Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss Completed NCT00352846 Phase 3 Zoledronic Acid;Vitamin D;Calcium Carbonate
10 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Completed NCT00755040 Phase 3 cyclosporine ophthalmic emulsion
11 Stem Cell Transplantation for Patients With Hematologic Malignancies Completed NCT00152139 Phase 3 Chemotherapy and antibodies
12 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases Completed NCT00438958 Phase 3
13 A Study of Actonel for the Prevention of Bone Loss Completed NCT00452439 Phase 3 Actonel (Risedronate)
14 BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) Completed NCT00088530 Phase 3 pixantrone, cyclophosphamide, vincristine, rituximab, prednisone;Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab
15 Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients Completed NCT00577993 Phase 3 Fludarabine;Novantrone;Decadron;Rituximab;Interferon;Doxorubicin;Vincristine;Bleomycin;Cyclophosphamide;Etoposide;Cisplatin;Ara-C;Methyl-Prednisolone;Procarbazine;Prednisone
16 Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies Completed NCT00186823 Phase 3 TBI, systemic chemotherapy and antibodies as follows:
17 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
18 Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women Completed NCT01052051 Phase 3
19 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
20 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
21 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. Completed NCT00330759 Phase 3 Zoledronic Acid
22 A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma Completed NCT01649856 Phase 3 CHOP;rituximab [MabThera/Rituxan];rituximab [MabThera/Rituxan]
23 Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy Completed NCT01016548 Phase 3
24 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
25 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
26 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
27 Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA Completed NCT00455312 Phase 2, Phase 3 Campath 1H;Cyclophosphamide;Fludarabine;antithymocyte globulin;Methylprednisolone
28 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
29 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
30 A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors Completed NCT00186901 Phase 3 Calcium carbonate (Tums), vitamin D
31 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
32 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
33 Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies Completed NCT01188798 Phase 3 Methotrexate;Pentostatin
34 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3 supersaturated calcium phosphate rinse
35 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
36 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
37 First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. Completed NCT00801281 Phase 3 Rituximab;Cyclophosphamide;Doxorubicin;Vincristine;Prednisone 1;Prednisone 2
38 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia Completed NCT00022737 Phase 3 asparaginase;cyclophosphamide;cyclosporine;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;ifosfamide;imatinib mesylate;leucovorin calcium;mercaptopurine tablet;methotrexate;pegaspargase;vincristine sulfate
39 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
40 ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy Completed NCT00816049 Phase 3 6MPindividualized;6MPfixed
41 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
42 Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer Completed NCT00075478 Phase 3 Fludarabine Phosphate;Mycophenolate Mofetil;Cyclosporine
43 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Recruiting NCT03117751 Phase 2, Phase 3 Prednisone;Vincristine;Daunorubicin;Pegaspargase;Erwinase®;Rituximab;Cyclophosphamide;Cytarabine;Mercaptopurine;Dasatinib;Methotrexate;Blinatumomab;Ruxolitinib;Bortezomib;Dexamethasone;Doxorubicin;Etoposide;Clofarabine;Vorinostat;Idarubicin
44 Double Cord Versus Haploidentical (BMT CTN 1101) Recruiting NCT01597778 Phase 3
45 Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Recruiting NCT02443077 Phase 3 Carmustine;Cyclophosphamide;Cytarabine;Etoposide;Ibrutinib;Melphalan
46 Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome Recruiting NCT02231879 Phase 3 Plerixafor;G-CSF
47 OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine Recruiting NCT01478542 Phase 3 Conventional Vincristine;Liposomal Vincristine;Ricover-scheme rituximab;optimised rituximab-schedule
48 A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) Recruiting NCT02213263 Phase 3
49 Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission Recruiting NCT03267433 Phase 3
50 R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma Recruiting NCT02428751 Phase 3 Pegylated liposomal doxorubicin;Doxorubicin;Rituximab;Cyclophophamide;Vincristine;Prednisone

Search NIH Clinical Center for Primary Bone Lymphoma

Genetic Tests for Primary Bone Lymphoma

Anatomical Context for Primary Bone Lymphoma

MalaCards organs/tissues related to Primary Bone Lymphoma:

39
Bone, Bone Marrow, T Cells, B Cells, Myeloid, Kidney, Nk Cells

Publications for Primary Bone Lymphoma

Articles related to Primary Bone Lymphoma:

(show top 50) (show all 77)
id Title Authors Year
1
Case of polyostotic primary bone lymphoma successfully treated with immunochemotherapy and consolidation radiotherapy. ( 28249886 )
2017
2
The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma. ( 28225435 )
2017
3
Primary bone lymphoma of radius and tibia: A case report and review of literature. ( 28403103 )
2017
4
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center. ( 28817403 )
2017
5
Primary bone lymphoma of the talus: a challenging diagnosis. ( 28862737 )
2017
6
Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder Presenting as Primary Bone Lymphoma in a Patient with Rheumatoid Arthritis. ( 27523005 )
2016
7
A rare case report of primary bone lymphoma and a brief review of the literature. ( 27563248 )
2016
8
Clinical characterization and outcome of primary bone lymphoma: a retrospective study of 61 Chinese patients. ( 27357354 )
2016
9
Unexpected primary bone lymphoma. ( 27939644 )
2016
10
Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution. ( 25895753 )
2015
11
Primary bone lymphoma with multifocal osteolytic lesions: a rare case report with review of literature. ( 26770955 )
2015
12
Stage IE Primary Bone Lymphoma:Limb Salvage for Local Recurrence. ( 25692168 )
2015
13
Utility of F-18 FDG PET/CT on the evaluation of primary bone lymphoma. ( 26388466 )
2015
14
Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience. ( 24673481 )
2014
15
Primary bone lymphoma of the left radius: a case report and related literature review. ( 24717101 )
2014
16
Evaluation of primary bone lymphoma and the importance of positron emission tomography. ( 24901932 )
2014
17
Incidental pedal manifestation of primary bone lymphoma: a case report. ( 24901590 )
2014
18
18F-FDG PET/CT Demonstrating Primary Bone Lymphoma of the Extremities Mimicking an Inflammatory Peripheral Arthropathy. ( 25140543 )
2014
19
Primary bone lymphoma: A case report and review of the literature. ( 25202366 )
2014
20
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma. ( 24723955 )
2014
21
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study). ( 24383942 )
2014
22
Primary bone lymphoma - experience of oncological orthopaedics department in BrzozA^w. ( 25058108 )
2014
23
Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center. ( 24008727 )
2013
24
Multifocal primary bone lymphoma: durable complete remission after R-CHOP chemotherapy. ( 23704456 )
2013
25
Primary bone lymphoma in a 10-year-old boy. ( 24617185 )
2013
26
Primary bone lymphoma with multiple vertebral involvement. ( 24125988 )
2013
27
Primary Bone Lymphoma of Humerus Diagnosed by FNAC- A Rare Case Report. ( 24426747 )
2013
28
Primary bone lymphomas thought to be osteomyelitis urgently demand a rapid diagnosis in bone pathology. ( 23155259 )
2012
29
Primary bone lymphoma of the shoulder. ( 22812585 )
2012
30
Primary bone lymphoma. ( 22402011 )
2012
31
Clinical characteristics and outcomes of primary bone lymphoma in Korea. ( 23071477 )
2012
32
Primary bone lymphoma involving bilateral tibia. ( 22641233 )
2012
33
Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study. ( 22079728 )
2012
34
A rare case of primary bone lymphoma mimicking a pelvic abscess. ( 22004625 )
2011
35
Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trial. ( 20638196 )
2011
36
Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma: two case reports. ( 21475602 )
2011
37
MR findings of primary bone lymphoma in a 15-year-old girl: emphasis on diffusion-weighted imaging. ( 21076823 )
2011
38
Primary bone lymphoma: a clinicopathological retrospective study of 28 patients in a single institution. ( 22091312 )
2011
39
F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis. ( 21637060 )
2011
40
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients. ( 21816370 )
2011
41
Primary bone lymphoma: a report of two cases and review of the literature. ( 21119256 )
2010
42
Primary bone lymphoma--the University of Miami experience. ( 19860629 )
2010
43
Primary bone lymphoma: a set of unique problems in management. ( 20055655 )
2010
44
Primary bone lymphoma: polyostotic disease presenting as a cauda equina syndrome. ( 21085013 )
2010
45
Primary bone lymphoma presenting as a monoarthritis. ( 19131765 )
2009
46
Primary bone lymphoma of the scapula. ( 20009414 )
2009
47
Primary bone lymphoma of the mandible and thyroid incidentaloma identified by FDG PET/CT: a case report. ( 19829800 )
2009
48
Primary bone lymphoma. ( 19886726 )
2009
49
Primary bone lymphoma: a series from a cancer institute in Pakistan. ( 19288950 )
2009
50
Bisphosphonates and primary bone lymphoma. ( 19373673 )
2009

Variations for Primary Bone Lymphoma

Expression for Primary Bone Lymphoma

Search GEO for disease gene expression data for Primary Bone Lymphoma.

Pathways for Primary Bone Lymphoma

GO Terms for Primary Bone Lymphoma

Sources for Primary Bone Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....